title: Islet neogenesis: a possible pathway for beta-cell replenishment.
abstract: Diabetes, particularly type 1 diabetes, results from the lack of pancreatic β-cells. β-cell replenishment can functionally reverse diabetes, but two critical challenges face the field: 1. protection of the new β-cells from autoimmunity and allorejection, and 2. development of β-cells that are readily available and reliably functional. This chapter will examine the potential of endogenous replenishment of pancreatic β-cells as a possible therapeutic tool if autoimmunity could be blunted. Two pathways for endogenous replenishment exist in the pancreas: replication and neogenesis, defined as the formation of new islet cells from pancreatic progenitor/stem cells. These pathways of β-cell expansion are not mutually exclusive and both occur in embryonic development, in postnatal growth, and in response to some injuries. Since the β-cell population is dramatically reduced in the pancreas of type 1 diabetes patients, with only a small fraction of the β-cells surviving years after onset, replication of preexisting β-cells would not be a reasonable start for replenishment. However, induction of neogenesis could provide a starting population that could be further expanded by replication. It is widely accepted that neogenesis occurs in the initial embryonic formation of the endocrine pancreas, but its occurrence anytime after birth has become controversial because of discordant data from lineage tracing experiments. However, the concept was built upon many observations from different models and species over many years. Herein, we discuss the role of neogenesis in normal growth and regeneration, as learned from rodent models, followed by an analysis of what has been found in humans.
authors.affiliation: Joslin Diabetes Center, Department of Medicine, Harvard Medical School, 1 Joslin Place, Boston, MA 02215, USA. susan.bonner-weir@joslin.harvard.edu
authors.forename: Susan
authors.initials: S
authors.lastname: Bonner-Weir
authors.forename: Lili
authors.initials: L
authors.lastname: Guo
authors.forename: Wan-Chun
authors.initials: WC
authors.lastname: Li
authors.forename: Limor
authors.initials: L
authors.lastname: Ouziel-Yahalom
authors.forename: Philippe A
authors.initials: PA
authors.lastname: Lysy
authors.forename: Gordon C
authors.initials: GC
authors.lastname: Weir
authors.forename: Arun
authors.initials: A
authors.lastname: Sharma
mesh_terms: D000818:Animals; D002454:Cell Differentiation; D049109:Cell Proliferation; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology*; D006801:Humans; D050417:Insulin-Secreting Cells / Q000166:cytology*; D007515:Islets of Langerhans / Q000166:cytology*